Posts in category

In Depth


One of the key health-related tasks of the re-elected Coalition government will be to ensure a solution to the supply of the expensive new Hepatitis C medicines. The scale of …

Pharmacists need to play a key role in helping people with ongoing pain to get assistance, write Dr Esther Lau, Prof Lisa Nissen and Tony Hall You know that awful …

Weekly Dose: triptans, drugs that relieve migraine but only if taken at the right time Michael Vagg, Barwon Health Triptans are a group of drugs targeted at alleviating symptoms of …

In December 2015 the Pharmacy Board of Australia (PBA) made a decision that was a game changer for Australian pharmacists, says Joe Demarte, PSA national president That decision was to revise …

Each pharmacy, and the wider industry, needs to put their heart into professional services, writes Ian Fredericks I firmly believe that community pharmacy has divided itself into two distinct models: the …

Debbie Rigby rounds up the latest research news Comparison of the Male Osteoporosis Risk Estimation Score (MORES) With FRAX in Identifying Men at Risk for Osteoporosis A comparison of the …

Things are not going to miraculously get easier for community pharmacy, so be prepared to work together for results, says Linda Miller  There’s been a lot of waiting in community …

Discussing medicines and Baby mustn’t stop when a baby is born, writes Karalyn Huxhagen Customers will ask about medications during their pregnancy. There are many myths and it is the …

With pharmacist influenza vaccination here to stay, pharmacy’s role in battling flu is only going to grow. In April 2016, pharmacist vaccinations became available in Queensland permanently, and less than …

NSW PDL Director Curtis Ruhnau takes a look at some of the more common areas of potential risk that PDL regularly sees. Patient profile and prescription intake Patient profile and …

Weekly Dose: sofosbuvir – what’s the price of a hepatitis C cure? Greg Dore, UNSW Australia and Marianne Martinello, UNSW Australia Sofosbuvir is one of a number of new direct-acting …

Despite the gloom settling over the pharmacy sector, there’s actually more opportunities out there than ever, writes Karalyn Huxhagen Opportunities for those of us pharmacists of a more mature age …